key: cord-0864381-efpgkj7l authors: de Oliveira, Karoline Faria; de Oliveira, Jacqueline Faria; Wernet, Monika; Carvalho Paschoini, Marina; Ruiz, Mariana Torreglosa title: COVID‐19 and pregnancy: A scoping review on pregnancy characteristics and outcomes date: 2021-05-16 journal: Int J Nurs Pract DOI: 10.1111/ijn.12956 sha: 27cdb35f977ed09664522964794e1fc9bdda9c8f doc_id: 864381 cord_uid: efpgkj7l AIM: The study aim was to map clinical characteristics and the evolution of pregnancies in pregnant women with confirmed diagnosis of SARS‐CoV‐2 infection. METHODS: Searching four databases, studies were investigated that described the evolution of pregnancies in women diagnosed with SARS‐CoV‐2 infection through laboratory tests. A scoping review was undertaken, including 35 articles published in English. Two pairs of independent researchers synthesized the data. RESULTS: Most studies were case studies or case series and had a low risk of bias. A predominance of cases was found in women over the age of 30 years who got infected in the third term of pregnancy and who had comorbidities. The prematurity index varied with the heterogeneity of the samples, and the cases of abortion occurred in combination with severe forms of infection. Caesarean section deliveries predominated, indicated mainly by respiratory decompensation caused by infection. Most women were discharged. CONCLUSION: Based on the reviewed studies, the profile and evolution of pregnant women infected with COVID‐19 could be evaluated. • The characteristics of pregnancy associated with COVID-19 infection turn obstetric care into a constant challenge. What this paper adds? • The review presents the profile of pregnant women infected by SARS-CoV-2, with laboratory confirmation using the diagnostic reference standard (PCR). • This review presents the profile of pregnant women infected with SARS-CoV-2 and the outcomes of the infection and pregnancy. The implications of this paper: • Based on the knowledge of the profile, public policies can be planned to prevent and manage infection among pregnant and postpartum women. • Further studies are suggested, mainly follow-up studies of cohorts with pregnant women infected with SARS-CoV-2 to expand knowledge about the profile and obstetric outcomes. Since the detection of SARS-CoV-2, responsible for the infection, which was later declared a pandemic by the World Health Organization (WHO), it has infected more than 105 million people and led to more than two million deaths (World Health Organization, WHO, 2021) . Pregnancy conveys particular vulnerabilities in relation to this infection. The gestational period is a unique, particular immune status, in which the pregnant woman needs to acquire tolerance to the allogeneic embryo/foetus and, at the same time, protect herself and the concept from pathogens. In this context, three immunological stages are described: pre-inflammatory (moment of implantation of the placenta), which occurs in the first term; anti-inflammatory (when the adaptation provides foetal growth and development), in the second term and, finally, pro-inflammatory, in the third term, which consists in preparing for the expulsion of the foetus (childbirth; Mor et al., 2017) . During pregnancy, the physiological changes in the respiratory tract, such as edema and increased pulmonary expansion, turn the pregnant woman more susceptible to respiratory viral infections. Thus, when SARS-Cov-2 infection is associated with pregnancy, increased inflammatory processes are observed, mainly in the first and third trimesters (pre-and pro-inflammatory states), exacerbating the severity of the cases . The particularities of pregnancy associated with COVID-19 infection turn obstetric care into a constant challenge (Poon et al., 2020) . Hence, as this is an emerging disease, hardly explored concerning the effects on pregnant women/foetuses and infants, and given the severe results of previous pandemics, the development of this study is justified. The aim of this scoping review was to map clinical characteristics and the evolution of pregnancies in pregnant women with confirmed diagnosis of SARS-CoV-2 infection. Scoping review according to the method of the Joanna Briggs Institute (JBI), aiming to map the scientific evidence associated with key concepts related to a specific phenomenon (Colquhoun et al., 2014; Lockwood & Tricco, 2020; Peters et al., 2015; Tricco et al., 2018 ; the review was registered at osf.io/hp25n). The research question was based on the Population, Concept and Context (PCC) strategy, establishing P for population, C for pregnancy and C for clinical and obstetric aspects of SARS-Cov-2/COVID-19 infection. Based on these definitions, the guiding question was 'What evidence is available in the literature about the clinical and obstetric aspects of SARS-Cov-2 infection during pregnancy?' Data collection took place on 15 July 2020, and searches were carried out in the U.S. National Library of Medicine National Institutes In this review, we included studies on the subject of coronavirus infection and pregnancy that addressed clinical, obstetric characteristics and outcomes in women with laboratory proof of infection using PCR (polymerase chain reaction), published in Portuguese, Spanish and English, dated 2020. The exclusion criteria included review studies, editorials, expert opinions and studies whose samples included pregnant women with clinical suspicions of the disease in their analysis. The level of evidence was not considered as an exclusion criterion because it is a new topic, with a reduced possibility of finding articles with a better level of evidence. Thus, 553 articles were identified in the four databases, and one article was added in the search based on the references analysed. The PRISMA method-Preferred Reporting Items for Systematic Reviews and Meta-Analyses (Tricco et al., 2018) -was adopted to systematize the inclusion process of the studies (Figure 1 ). In the first stage, the choice of the articles was based on the analysis of titles and abstracts. Then, the full version was read for the final selection, extracting 35 studies from the databases. The sources of the analysed databases were PubMed ® , CINAHL, LILACS and Web of Science™. Articles were excluded when duplicates; written in nonestablished languages; beyond the topic; that did not meet the eligibility criteria (cases without laboratory proof of infection), literature review articles and qualitative research/expert opinion/editorial. The Joanna Briggs Institute Appraisal Tools (JBI, 2014) were used to evaluate the methodological quality and risk of bias of the included studies. The tools allowed to classify the articles as high risk of bias (scores less than 50%), moderate risk of bias (scores between 50% and 70%) and low risk of bias (scores above 70%). The level of evidence was classified according to the type of study, according to evidence level II of Melnyk and Fineout-Overholt (2005) . The data were synthesized by two pairs of independent researchers. An instrument structured by the researchers, tested through a pilot study, was used to extract the data from the studies, following the guidelines of the JBI (JBI, 2014), which included the identification of the article, year and place of the study; the methodological characteristics; the evaluation of the methodological rigour and the notes and discussions about the thematic focus of this scoping review. The F I G U R E 1 Selection flow of review articles according to PRISMA de OLIVEIRA ET AL. extracted information was tabulated for data synthesis, and the analysis of the results was descriptive, showing a synthesis of each primary study included in this review. After the analysis by the four researchers, given the inclusion and exclusion criteria, 35 articles were selected for qualitative synthesis. All the articles were published in 2020, in English. Among the included studies, 77.1% were case studies, 20% descriptive reports and one cohort study (2.9%). The application of tools to assess the methodological quality and risk of bias from the Joanna Briggs Institute Appraisal Tools revealed a high risk of bias (score = 42%) in one study, moderate risk (scores between 50 and 70%) in seven (20%) and low risk of bias in 27 (77.1%) studies. All of the articles included presented a description of the diagnostic method and used PCR as a reference standard for the diagnosis of COVID-19 in pregnant women. The most neglected item was the complete description of the treatments employed. Despite the methodological limitations found, it was decided not to exclude the articles as this is a recent topic. Regarding the producer countries, 34.3% of the articles came from China and 31.4% from the United States, although studies on the subject were produced more widely across the world. When adding up the studies, 685 pregnant women were found who had COVID-19, ranging from asymptomatic to severe cases of the disease. The flowchart displays the exclusion diagram, according to each database investigated (Figure 2 ). Table 1 shows the country of origin, the number of pregnant women included (N) and the methodological quality assessment score by JBI Appraisal Tools. When the maternal age was analysed, a mean of 31.2 ± 4.5 years was found, obtained by analysing the age or mean ages presented in the studies. The stratification by age group showed a predominance in women over the age of 30 years. Regarding parity, multiparous women were predominant in 13 case studies, and the prevalence of multiparity ranged from 52.4% F I G U R E 2 Article selection flow and reasons for exclusion from the review, according to the PRISMA guidelines, 2020 to 100% of cases. In the studies evaluated, however, no predominance of cases associated with parity was found. In the evaluation of the gestational term in which the infection by COVID-19 occurred, infected pregnant women were found in the three trimesters, although with a higher prevalence in the third gestational trimester. The percentage of infection in the third trimester ranged from 38.5% to 100%. The presence of comorbidities in pregnancy was evaluated in 30 studies (85.7%), and, in eight (26.7%), the pregnant women had no comorbidities. Twenty-two studies described comorbidities, with prevalence rates ranging from 2.3% to 100% of the pregnant women evaluated. Among the most frequent comorbidities, there was a predominance of endocrine and metabolic diseases and/or alterations; obesity was reported in four case studies, ranging between 43% and 69% of the infected pregnant women. Gestational diabetes (GDM) was described in three cases, ranging from 6.7% to 50% of pregnant women, and Type II diabetes mellitus was reported in three studies; hypothyroidism was evidenced in six studies, with a frequency of 5% to 14.5% of pregnant women included in the studies. Conditions of the cardiovascular system during pregnancy were also associated with COVID-19 infection, with cases of pre-eclampsia. One study pointed out that 15% of the infected pregnant women had hypertensive syndromes. Although less frequent, pregnant women with chronic heart disease infected by COVID-19 were observed. Two studies described the need for differential diagnosis of severe infection by COVID-19 in cases of pre-eclampsia and HELLP. T A B L E 1 Synthesis of outcomes and evidence of selected articles (N = 35), 2020 In five studies, participants were described who remained pregnant, with discharge and cure of the infection. Between 26.7% and 61.5% of the participants maintained the pregnancy. Eleven studies had term delivery (31.4%) as the outcome and seven (20%) premature birth. Twelve studies (34.3%) described that the frequency of full-term births ranged from 23.1% to 100%, against 8.7% to 100% for premature birth, with differences due to the great heterogeneity of the samples studied. As for the type of delivery, in three (8.6%) case studies, the pregnancies evolved into normal delivery, and, in one of these, delivery was facilitated by the use of a vacuum pump; two studies used a relief forceps in 10% to 17.4% of the cases, and caesarean section was described in 10 (28.5%) articles. In 12 studies, the frequency of delivery types was mentioned, with vaginal births ranging from 6.7% to 100% and caesarean sections from 21.7% to 100%. In five studies, abortion was the gestational outcome, and, in one of them, the pregnancy was discovered after exacerbation of severe ulcerative colitis, and it was not possible to determine the gestational age. In the other studies in which abortion was the outcome, the occurrence ranged from 6.3% to 50%. All pregnant women who experienced abortion had severe forms of COVID-19. Most studies indicated good maternal outcomes, whereas only three (8.6%) reported maternal deaths, totalling 12 maternal deaths (1.8%). One of these studies was a cohort with 427 postpartum women which showed 1% maternal death rate (Knight et al., 2020) . Another study (Hantoushzadeh et al., 2020) aimed to describe the cases of maternal deaths and those that generated permanent disability in pregnant women with COVID-19, attended in the United States. Seven pregnant women died, and two remained hospitalized with a definitive tracheostomy and on mechanical ventilation (Hantoushzadeh et al., 2020) . The third study (Vallejo & Ilagan, 2020) described a case in which the multiparous and obese postpartum woman, who had a caesarean section for respiratory decompensation by COVID-19, went on to acute renal failure at 17 h postpartum. Death occurred 36 h after the caesarian section. The gestational outcomes related to delivery, such as term or preterm, type of delivery and the indication of surgical delivery are described in Table 3 . The results of this review present the profile of pregnant women infected by SARS-CoV-2 globally, confirmed by PCR, a reference standard for the diagnosis in pregnant women. It is important to highlight that the physiological changes that are normal in pregnancy predispose pregnant women to acquire viral infections and, if they have any infection, they tend to present more severe forms, including of COVID-19 (Poon et al., 2020) . With the growth of the foetus, the woman starts to breathe faster, and this breathing is called costal breathing, that is, breathing high in the thoracic and non-abdominal region. The compression of the respiratory system by the growing foetus causes edema (swelling) and increased lung expansion. With this increase and swelling, the pregnant woman becomes more susceptible to respiratory infections . Also, there is an increase in volume and blood flow during pregnancy. This increased flow, to transport nutrients to the foetus, means that, when presenting infections, pregnant women may present more severe and intense forms of the infection. The rapid breathing and the increased blood flow of the pregnant woman, which can be observed by the increase in heart rate and decrease in pressure, also make it difficult to assess the cases, especially of the COVID-19 infection, as these are some of the characteristic signs and symptoms of the infection for the general population, whereas they may just be normal changes in pregnancy . Altogether, these physiological events of pregnancy can predispose pregnant women to infection by and hamper the diagnosis of the infection, deserving to be evaluated and discussed. Studies conducted in the United States showed universal screening results with PCR for pregnant women corresponding to 1.9% of positive results in symptomatic and 13.5% in asymptomatic cases. Thus, the authors advocate universal screening for all pregnant women, aiming for obstetric/neonatal care planning and the rational use of personal protective equipment-a protective measure for mothers/newborns and health teams (Sutton et al., 2020) . Screening is important for the sake of detection and early intervention in COVID-19 cases during pregnancy, and maintaining prenatal care is important to avoid complications in pregnant women with preexisting comorbidities (Quiao, 2020) . These data justify the choice of positive PCR as the inclusion criterion of this review. Reference Quiancheng et al., 2020; Yang et al., 2020) and in the United States (Ellington et al., 2020) There was no difference in cases associated with parity in the reviewed articles. Only one Chinese study , evaluating 118 pregnant women, showed a slight predominance of infections among primiparous women (52%). Similar to the results of the present review, studies point to infection with COVID-19 being identified throughout the pregnancy period, with a higher incidence in the third trimester Dashraat et al., 2020; Mullins et al., 2020; Quiancheng et al., 2020; Sahin et al., 2021; Stumpfe et al., 2020; Zaigham & Andersson, 2020) . Due to the limited number of infections in the first trimester, it cannot be argued whether COVID-19 is a cause of early-stage abortion Schwartz & Graham, 2020 hypertensive syndromes and type II diabetes mellitus (Sahin et al., 2021) . A Chinese study, involving 17 pregnant women, pointed out a predominance of cases of anaemia (29%), gestational diabetes (12%) and gestational hypertension (6%) . In another, involving 28 pregnant women, unspecified diabetes (7.1%); hepatitis B (7.1%); unspecified hypertension (3.6%) and hypothyroidism (3.6%) were identified (Quiancheng et al., 2020) . American statistics also point to the predominance of pregnant women with comorbidities (88.1%): with chronic lung diseases (21.8%); diabetes (15.3%) and cardiovascular diseases (14%; Ellington et al., 2020) . The presence of comorbidity is a contradictory result in the literature. However, the fact that the disease is not controlled can predispose to greater risks during the infection. Obesity, hypertensive syndromes and gestational diabetes have been associated with severe cases of COVID-19 in pregnant women in Sweden (Collin et al., 2020) . In Brazil, higher maternal mortality rates occurred in pregnant women with cardiovascular diseases, obesity and gestational diabetes (Takemoto et al., 2020) . For these authors, comorbidities can contribute to unfavourable outcomes (Takemoto et al., 2020) . The reduction of unnecessary consultations and examinations, aimed at avoiding the exposure of pregnant women; lifestyle interventions; remote monitoring and risk stratification, maintaining face-to-face consultations for more severe cases, are presented as alternatives to control the main complications in pregnancy (Barton et al., 2020; Murphy, 2020; Thangaratinam et al., 2020) . 15% infection by streptococcus B; 10% nuchal cord; 10% foetal macrosomia; 5% had received cancer treatment; 5% placenta accreta; 5% postpartum atony; 5% placenta previa and 5% twin pregnancy. de OLIVEIRA ET AL. Reference Dashraat et al., 2020; Di Mascio et al., 2020; Ferrazzi et al., 2020; Karimi-Zarchi et al., 2020; Panahi et al., 2020; Quiancheng et al., 2020; Sahin et al., 2021; Schwartz, 2020; Smith et al., 2020; Stumpfe et al., 2020) . The high prevalence of premature births associated with COVID-19 infection can be explained by maternal lung impairment, which decreases the placental flow (Stumpfe et al., 2020) . Abortion was presented as an outcome in five studies, with great variation in frequency, although all of these pregnant women had severe forms of COVID-19. Studies with pregnancy profiles indicate rates from 2% to 14.3% of abortions secondary to infection Dashraat et al., 2020; Quiancheng et al., 2020; Sahin et al., 2021) . The predominant delivery route was caesarean section, justified by maternal respiratory decompensation secondary to COVID-19. Infection with SARS-Cov-2 is not an absolute indication for caesarean delivery, but the clinical conditions of the pregnant woman, gestational age and foetal viability should be evaluated (Gildlof et al., 2020; ISUOG, 2020; Karimi-Zarchi et al., 2020; Qi et al., 2020; Rasmussen et al., 2020; RCOG & RCM, 2020) . The data presented are corroborated by other studies indicating a predominance of caesarean sections, with rates ranging from 60.7% to 100% Di Mascio et al., 2020; Mullins et al., 2020; Panahi et al., 2020; Quiancheng et al., 2020; Sahin et al., 2021; Smith et al., 2020; Stumpfe et al., 2020; Yang et al., 2020; Zaigham & Andersson, 2020) . It should be noted that a caesarean section needs precise indications, but in cases of severe infection, it may be one of the most suitable relief and treatment measures, with good postpartum results (Oliva et al., 2020) . Most studies indicated a favourable maternal outcome, with discharge and cure Dashraat et al., 2020; Mullins et al., 2020; Quiancheng et al., 2020; Schwartz & Graham, 2020; Smith et al., 2020) . The sum of all deaths reached 1.8% of maternal deaths. One case review reported the death of 6.4% of pregnant women infected with SARS-CoV-2 (Karimi-Zarchi et al., 2020), and, based on the death records, a maternal mortality rate of 12.7% was identified in Brazilian pregnant women (Takemoto et al., 2020) . One study pointed out that interrupted routine care and reduced access to healthy eating can have devastating impacts on the lives of women and infants (Roberton et al., 2020) , serving as an alert for governments and health professionals. The association between increased maternal mortality and COVID-19 pandemic can also be explained by the pregnant woman's hesitation to seek care, out of fear of the disease; financial and/or transportation problems that hinder access to health services; maternal isolation of infected pregnant women in distant regions, which compromise timely care in severe conditions and reduction of consultations, supplies and health professionals, compromising the quality of care. Thus, maternal mortality secondary to COVID-19 demonstrates the disparities of minorities and the vulnerable population (Osanan et al., 2020) . In summary, this review shows that pregnant women are predisposed to infection by COVID-19 due to the physiological T A B L E 3 (Continued) de OLIVEIRA ET AL. characteristics of pregnancy. As they were not included in the priority group for immunization and can present severe forms of the disease, the importance of adopting preventive measures such as strict hand hygiene, wearing a mask, maintaining social distance and staying at home is reinforced. In case of symptoms, pregnant women need to seek assistance immediately for early treatment and, under no circumstances, should miss prenatal consultations, especially those pregnant women with comorbidities. This profile and information should guide health managers for public health actions. Being a novel disease with incipient research on the theme, articles with a moderate risk of bias were included in the analyses to map the theme. With rapid updating of the literature and an increase in the number of cases, different results may arise, and these results may only be relevant at this time. Thirty-five studies were found that assessed cases of pregnant women who had COVID-19. Overall, cases in women older than 30 years were predominant: who became infected in the third trimes- They were not included in the priority group for immunization and can present severe forms of the disease; studies are still incipient about the disease, in general and in the specific audience, with intense production of publications in the period. Thus, this study may reflect a current picture of the pandemic. In this sense, this study is an initial starting point for discussions on the impact of COVID-19 on pregnancy. This study was developed with the support of the CNPq-Call MCTIC/CNPq/FNDCT/MS/SCTIE/Decit No. 07/2020-Research to cope with COVID-19, its consequences and other severe acute respiratory syndromes-Process 141513/2020-3. Severe COVID-19 during pregnancy and possible vertical transmission Placental pathology in COVID-19 positive mothers: Preliminary finding A proposed plan for prenatal care to minimize risks of COVID-19 to patients and providers: Focus on hypertensive disorders of pregnancy Acute respiratory distress syndrome in a preterm pregnant patient with coronavirus disease 2019 (COVID-19) Sucessful treatment of preterm labor in association with acute COVID-19 infection Clinical analysis of ten pregnant women with COVID-19 in Wuhan, China: A retrospective study Clinical characteristics and diagnostic challenges of pediatric COVID-19: A systematic review and meta-analysis Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: A retrospective review of medical records Clinical characteristics of pregnant women with COVID-19 in Wuhan Safety and efficacy of different anesthetic regimens for parturients with COVID-19 undergoing cesarean delivery: A case series of 17 parturients Public Health Agency of Sweden's brief report: Pregnant and postpartum women with SARS-CoV-2 infection in intensive care in Sweden Scoping reviews: Time for clarity in definition, methods, and reporting Coronavirus disease 2019 (COVID-19) pandemic and pregnancy Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: A systematic review and meta-analysis Characteristics of women of reproductive age with laboratory-confirmed SARS-Cov-2 infection by pregnant status Report of positive placental swabs for SARS-CoV-2 in an asymptomatic pregnant woman with COVID-19 Executive management summary and short report of outcome COVID-19 and HELLP: Overlapping clinical pictures in two gravid patients COVID-19 in pregnancy with comorbidities: More liberal testing strategy is needed No evidence of vertical transmission of SARS-CoV-2 after induction of labour in an immunesuppressed SARS-CoV-2-positive patient Maternal death due COVID-19 An uncomplicated delivery in a patient with COVID-19 in the United States ISUOG interim guidance on 2019 novel coronavirus infection during pregnancy and puerperium: Informations for healthcare professionals Joanna Briggs institute reviewers' manual Lung ultrasound and computed tomographic findings in pregnant woman with COVID-19 Vertical transmission of coronavirus disesase 19 (COVID-19) from infected pregnant mothers to neonates: A review Probable congenital SARS-CoV-2 infection in a neonate born to a woman with active SARS-CoV-2 infection Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: National population based cohort study COVID-19 and acute coagulopathy in pregnancy The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptione study Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: A preliminary analysis Why are pregnant women susceptible to COVID-19? An immunological viewpoint Preparing scoping reviews for publication using methodological guides and reporting standards COVID-19 vaginal delivery-A case report Asymptomatic COVID-19 infection in late pregnancy indicated no vertical transmission Cesarean section in a pregnant woman with COVID-19: First case in Portugal Evidence-based practice in nursing and healthcare: A guide to best practice Pre-eclampsia-like syndrome induced by severe COVID-19: A prospective observational study The unique immunological and microbial aspects of pregnancy Coronavirus in pregnancy and delivery: Rapid review Managing diabetes in pregnancy before, during and after COVID-19 Clinical improvement of severe COVID-19 pneumonia in pregnant patient after caesarean delivery Do not forget our pregnant women during the COVID-19 pandemic Risks of novel coronavirus disease (COVID-19) in pregnancy, a narrative review Unlikely SARS-CoV-2 vertical transmission from mother to child: A case report Clinical course of coronavirus disease-2019 (COVID-19) in pregnancy Guidance for conducting systematic scoping reviews Global interim guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium from FIGO and allied partners: Information for healthcare professionals Pregnancy affected by SARSCoV-2 infection: A flash report from Michigan Safe delivery for pregnancies affected by COVID-19 & The six batch of Anhui Medical Team Aiding Wuhan for COVID-19 What are the risks of COVID-19 infection in pregnant women? Coronavirus disease 2019 (COVID-19) and pregnancy: What obstetricians need to know Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low income and middle-income countries: A modeling study. The Lancet Global Health Management of acute severe ulcerative colitis in a pregnant woman with COVID-19 infection: A case report and review of the literature Royal College of Obstetricians & Gynaecologists & The Royal College of Midwives Update experience of a tertiary pandemic center on 533 pregnant women with COVID-19 infection: A prospective cohort study from Turkey An analysis of 38 pregnant women with of COVID-19, their newborn infants and maternal-fetal transmission of -SARS-CoV-2: Maternal coronavirus infections and pregnancy outcomes Potential maternal and infant outcomes from coronavirus 2019-n-CoV (SARS-CoV-2) infecting pregnant women: Lessons from SARS, MERS and other human coronavirus infections Placental pathology in COVID-19 Acute respiratory decompensation requiring intubation in pregnant women with SARS-CoV-2 (COVID-19) Maternal and neonatal outcomes associated with COVID-19 infection: A systematic review SARS-CoV-2 infection in pregnancy-A review of the current literature Universal screening for SARS-CoV-2 in women admitted for delivery The tragedy of COVID-19 in Brazil: 124 maternal deaths and counting Endocrinology in time of COVID-19: Diagnosis and management of gestational diabetes mellitus PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation A postpartum death due to coronavirus disease 2019 (COVID-19) in the United States Transplacental transmission of SARS-CoV-2 infection A patient with SARS-CoV-2 infection during pregnancy in Qingdao Coronavirus disease (COVID-19) situation dashboard Coronavirus disease 2019 among pregnant Chinese women: Case series data on the safety of vaginal birth and breastfeeding Emergency caesarean delivery in a patient with confirmed COVID-19 under spinal anaesthesia The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study Clinical features and outcomes of pregnant women suspected of coronavirus disease 2019 Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: A retrospective, single-centre, descriptive study. The Lancet Infectious Diseases Severe COVID-19 in a pregnant patient admitted to hospital in Wuhan Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies Update on clinical outcomes of women with COVID-19 during pregnancy COVID-19 and pregnancy: A scoping review on pregnancy characteristics and outcomes The authors declare no conflict of interest.